Venlafaxine for ADHD
Brand names of venlafaxine include: Trevilor (D), Efexor (CH), Efectin (A)
Venaflaxin came on the market in 1993 and is approved only for adults (18 years and older).1
Venlafaxine acts primarily at the serotonin level, secondarily at the norepinephrine level as a reuptake inhibitor (SSNRI = selective serotonin-norepinephrine reuptake inhibitor), and even less so at the dopamine level.1
Venlafaxine has only been tested in a few studies with a small number of subjects in relation to ADHD. The improvement in ADHD symptoms was very modest, while side effects were significant.2
We therefore advise against the use of venlafaxine in ADHD.
ATTENTION:
Regarding the entire group of serotonin reuptake inhibitors, there are concerns about their use in ADHD.
See ⇒ Comments on serotonin reuptake inhibitors (SSRIs) in ADHD In the article ⇒ Medications for ADHD - overview.
Müller, Candrian, Kropotov (2011), ADHS – Neurodiagnostik in der Praxis, Springer, Seite 22 ↥ ↥
Häßler (2009): substanzgebundene Alternativen in der Therapie von ADHS, Seite 175 f, in: Häßler (Hrsg) das ADHS Kaleidoskop – State of the Art und bisher nicht beachtete Aspekte von hoher Relevanz; medizinisch wissenschaftliche Verlagsgesellschaft ↥